Quarter
Charts

MEDIFAST, INC. — Earnings

Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR

← Calendar (this week)
Next earnings (estimated): Wed, April 1, 2026 — 32 days overdue (likely already filed but EDGAR cache cold). Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.
Recent · last 8 quartersFuture · next 8 quarters
YoY = vs same quarter prior year (seasonality-adjusted)

Recent earnings · last 8 quarters

Quarter endRevenueYoYNet IncomeYoYOp. Margin
2025-12-31$75M↓-36.9%———
2025-09-30$89M↓-36.2%$-2M↓-300.3%-4.6%
2025-06-30$106M↓-37.4%$2M↑+130.4%-1.0%
2025-03-31$116M↓-33.8%$-772K↓-109.3%-1.1%
2024-12-31$119M↓-37.7%$801K↓-86.7%0.6%
2024-09-30$140M↓-40.6%$1M↓-95.1%1.5%
2024-06-30$169M↓-43.1%$-8M↓-126.9%-4.7%
2024-03-31$175M↓-49.9%$8M↓-79.2%4.5%

Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.

Last earnings · FY2025 (Q4)

Revenue
$75M
↓-36.9% -$44M YoY

Earnings surprise · last 8 quarters

YoY % change · proxy for analyst surprise until estimates land

EPS history · last 10 fiscal years

diluted, GAAP, annual

Note: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.

Margin trends · 64 quarters

margin trajectory tells the operating-leverage story
Gross Margin↓-4.7pts
69.4%
Operating Margin↓-6.1pts
-4.6%
Net Margin↓-3.3pts
-2.5%

Go deeper

MED Sankey — flow of dollars

See how revenue waterfalls through every line item to net income for the latest reported quarter, with prior-period comparison.

Open Sankey

MED Key Metrics — EPS, ROE, ROIC

10 CFA-grade fundamental ratios — EPS, BVPS, ROE, ROA, ROIC, Debt/Equity, Current Ratio. Compare across years.

Open Key Metrics